Physician profile
Daniel Joyce
NPI 1710333182
$25,812.45
in general payments reported to CMS, 2019-2025
14 companies · $22K in 2025
The $22K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $256 · 2022: $138 · 2023: $414 · 2024: $2,660 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Food and Beverage: $3,456 · Travel and Lodging: $2,920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,042.00 |
| Food and Beverage | $3,456.16 |
| Travel and Lodging | $2,920.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $15,097.24 | 2024-2025 | Illuccix |
| Ferring Pharmaceuticals INC. | $4,186.10 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $2,903.15 | 2021-2025 | Erleada, Akeega, Balversa |
| Janssen Global Services, LLC | $1,792.30 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $432.02 | 2022-2025 | |
| Urogen Pharma, INC. | $366.27 | 2023-2025 | |
| Photocure INC | $359.03 | 2025 | Cysview |
| Intuitive Surgical, INC. | $245.08 | 2024 | |
| Medtronic, INC. | $132.27 | 2021 | |
| Boston Scientific Corporation | $103.07 | 2023 | Lithovue |
| Karl Storz Endoscopy-America | $77.68 | 2022 | |
| Immunitybio, INC. | $67.45 | 2024 | |
| Pfizer INC. | $50.79 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Joyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.